SCHEMBL4181107

SCHEMBL4181107

NC(CC(=O)O)Oc1cc(Cl)c(Cl)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
TDP1 Q9NUW8 2/20 0.39
TSHR P16473 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMO O15229 3/20 0.37
FFAR1 O14842 1/20 0.37
RECQL P46063 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
FKBP1A P62942 1/20 0.34
GABBR2 O75899 2/20 0.33
GABBR1 Q9UBS5 2/20 0.33
PPARA Q07869 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
NFKB1 P19838 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11596466 0.82 LMNA (0.42) LMNATDP1TSHRL3MBTL1KMO
SCHEMBL4185056 0.82 TDP1 (0.55) TDP1TSHRL3MBTL1FFAR1RECQL
SCHEMBL27635654 0.79 PPARA (0.46) LMNATDP1TSHRL3MBTL1KMO
SCHEMBL4182560 0.73 TSHR (0.60) LMNATDP1TSHRFFAR1SMN1; SMN2
SCHEMBL4181103 0.72 PPARA (0.46) LMNATDP1TSHRL3MBTL1KMO
SCHEMBL10537878 0.72 TSHR (0.40) LMNATDP1TSHRL3MBTL1KMO
SCHEMBL4173523 0.70 PPARG (0.50) LMNATSHRCYP2D6CYP2C9CYP2C19
SCHEMBL10881038 0.69 LMNA (0.40) LMNATDP1TSHRL3MBTL1FFAR1
Fenoprop SCHEMBL2419073 0.69 TSHR (0.56) LMNATDP1TSHRL3MBTL1SMN1; SMN2
Fenoprop SCHEMBL29385175 0.69 TSHR (0.56) LMNATDP1TSHRL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US claimed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP claimed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO claimed
US-20090227680-A1 Amino Acid Derivatives PFIZER, INC. (US) 2009-09-10 US disclosed
EP-1951655-A2 AMINO ACID DERIVATIVES Pfizer Limited (GB) 2008-08-06 EP disclosed
WO-2007057767-A2 AMINO ACID DERIVATIVES PFIZER LIMITED (GB) 2007-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227680-A1 Amino Acid Derivatives OPRL1, OPRK1, AVPR1A LMNA 3623/4885TDP1 4257/4885TSHR 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.